Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706739200 on January 7, 2008

J. Biol. Chem., Vol. 283, Issue 10, 6359-6366, March 7, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/10/6359    most recent
M706739200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillen, C. M.
Right arrow Articles by Walker, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillen, C. M.
Right arrow Articles by Walker, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Opacity Factor Activity and Epithelial Cell Binding by the Serum Opacity Factor Protein of Streptococcus pyogenes Are Functionally Discrete*Formula

Christine M. Gillen{ddagger}1, Harry S. Courtney§2, Kai Schulze, Manfred Rohde||, Mark R. Wilson{ddagger}, Anjuli M. Timmer**, Carlos A. Guzman, Victor Nizet**, G. S. Chhatwal||, and Mark J. Walker{ddagger}3

From the {ddagger}School of Biological Sciences, University of Wollongong, New South Wales 2522, Australia, the §Veterans Affairs Medical Center and Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38104, the Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany, the ||Department of Microbial Pathogenicity, Helmholtz Centre for Infection Research, Braunschweig, Germany D-38124, and the **Department of Pediatrics, Division of Pharmacology and Drug Discovery, University of California, San Diego, La Jolla, California 92093-0687

Serum opacity factor (SOF) is a unique multifunctional virulence determinant expressed at the surface of Streptococcus pyogenes and has been shown to elicit protective immunity against GAS infection in a murine challenge model. SOF consists of two distinct domains with different binding capacities: an N-terminal domain that binds apolipoprotein AI and a C-terminal repeat domain that binds fibronectin and fibrinogen. The capacity of SOF to opacify serum by disrupting the structure of high density lipoproteins may preclude its use as a vaccine antigen in humans. This study generated mutant forms of recombinant SOF with reduced (100-fold) or abrogated opacity factor (OF) activity, for use as vaccine antigens. However, alterations introduced into the N-terminal SOF peptide (SOF{Delta}Fn) by mutagenesis to abrogate OF activity, abolish the capacity of SOF to protect against lethal systemic S. pyogenes challenge in a murine model. Mutant forms of purified SOF{Delta}Fn peptide were also used to assess the contribution of OF activity to the pathogenic processes of cell adhesion and cell invasion. Using latex beads coated with full-length SOF, SOF{Delta}Fn peptide, or a peptide encompassing the C-terminal repeats (FnBD), we demonstrate that adhesion to HEp-2 cells is mediated by both SOF{Delta}Fn and FnBD. The HEp-2 cell binding displayed by the N-terminal SOF{Delta}Fn peptide is independent of OF activity. We demonstrate that while the N terminus of SOF does not directly mediate intracellular uptake by epithelial cells, this domain enhances epithelial cell uptake mediated by full-length SOF, in comparison to the FnBD alone.


Received for publication, August 14, 2007 , and in revised form, November 26, 2007.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1.

1 Recipient of an Australian Research Council Postgraduate Award.

2 Supported by research funds from the Dept. of Veterans Affairs.

3 To whom correspondence should be addressed: School of Biological Sciences, University of Wollongong, Wollongong, NSW, 2522, Australia. Tel.: 0061-2-4221-3439; Fax: 0061-2-4221-4135; E-mail: mwalker{at}uow.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. S. Courtney, Y. Li, W. O. Twal, and W. S. Argraves
Serum Opacity Factor Is a Streptococcal Receptor for the Extracellular Matrix Protein Fibulin-1
J. Biol. Chem., May 8, 2009; 284(19): 12966 - 12971.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement